All Resources

Dr Jeremy Pettus highlights key challenges when identifying adult-onset T1D versus T2D, which can lead to frustration and ineffective management. 

Dr Daniel Agardh discusses the multiple technologies now available for detecting islet autoantibodies associated with type 1 diabetes  

Dr Gun Forsander discusses how AI-powered risk stratification may be utilized to optimize T1D screening strategies 

An infographic describing the prevalence of and challenges faced in diagnosing adult-onset T1D 

T1D is a chronic, autoimmune disease with a complex, multifactorial etiology. Explore how genetics and environmental factors can trigger autoimmunity

Early identification of presymptomatic T1D and subsequent monitoring and education has a range  
of potential benefits 

Expert interview discussing the benefits of T1D screening and communication strategies employed when highlighting the importance of T1D screening 

Expert interviews discussing the learnings from and strategies implemented  during a real world T1D screening program 

Expert interviews discussing early identification of T1D including diagnosis and misdiagnoses 

Expert interviews discussing the fundamentals of T1D screening programs  

Expert interviews discussing psychosocial support for individuals at risk of T1D 

At the BR1DGE symposium at ATTD 2025, leading experts discussed how innovation can evolve the early detection and management of T1D (type 1 diabetes). 

This article is intended to be a summary only. Additional topics were covered in the live symposium in line with the applicable regulations but are not included on the BR1DGE platform.